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Abstract
Background: Natural killer (NK) cells represent a first line of defence against a developing cancer;
however, their exact role in colorectal cancer remains undetermined. The aim of the present study
was to evaluate the expression of CD16 and CD57 [immunohistochemical markers of natural NK
cells] in colorectal adenocarcinoma.
Methods:  Presence of NK cells was investigated in 82 colorectal adenocarcinomas.
Immunohistochemical analysis was performed, using 2 monoclonal antibodies (anti-Fc Gamma
Receptor II, CD16 and an equivalent to Leu-7, specific for CD-57). The number of immunopositive
cells (%) was evaluated by image analysis. The cases were characterized according to: patient
gender and age, tumor location, size, grade, bowel wall invasion, lymph node metastases and Dukes'
stage.
Results: NK cells were detected in 79/82 cases at the primary tumor site, 27/33 metastatic lymph
nodes and 3/4 hepatic metastases; they were detected in levels similar to those reported in the
literature, but their presence was not correlated to the clinical or pathological characteristics of
the series, except for a negative association with the patients' age (p = 0.031).
Conclusions: Our data do not support an association of NK cell tissue presence with clinical or
pathological variables of colorectal adenocarcinoma, except for a negative association with the
patients' age; this might possibly be attributed to decreased adhesion molecule expression in older
ages.
Background
Colorectal adenocarcinoma is a neoplasm in which prog-
nosis is mainly determined by the histological stage.
However, the prognosis of certain patient groups, espe-
cially those of intermediate stages, remains vague [1]. The
main weakness of the currently used prognostic markers
in colorectal adenocarcinoma, is their inability to point
out patients without metastases, whose clinical course
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will progress unfavorably and patients with metastatic dis-
ease who will have a relatively better outcome [1]. There-
fore, development of new prognostic markers is essential,
as they might help in the planning of more effective treat-
ment modalities. Markers of the host's immune response
could potentially be helpful in this field.
Natural killer (NK) cells play a pivotal role in innate
immunity and immunological surveillance. Their cyto-
toxic effects may be initiated without prior immunization
and thus NK cells have been considered as a first line of
defence of the host against a developing cancer [2,3]. In
spite of their small presence in tissue samples from color-
ectal adenocarcinomas, NK cells manifest a potent cyto-
toxic anti-tumor effect [3-5]. Expression of various protein
surface markers is essential for these cells to perform their
activities [2]. Among these markers, CD16 is used to iden-
tify active NK cells in immunohistochemical studies,
while CD57 is expressed on NK cell-like elements.
The aim of this study was to evaluate tissue presence of NK
cells in a series of colorectal adenocarcinomas and to
attempt to correlate their presence with clinical and path-
ological variables and prognostic markers of colorectal
cancer.
Methods
From June 1997 to May 2000, 82 patients from our
Department underwent colectomy, due to a diagnosis of
colorectal adenocarcinoma of conventional histologic
type. NK cell presence was examined via standard 3-step
immunohistochemical analysis (ABComplex), which was
performed on formalin-fixed, paraffin-embedded tissue
sections. Briefly, two appropriate monoclonal antibodies
were used (anti-Fc Gamma Receptor II, CD16 and an
equivalent to Leu-7, specific for CD-57, Dako, Glostrup,
Denmark) at dilutions of 1/200 with overnight incuba-
tion. Antigen retrieval was necessary and was performed
by usual microwave treatment. In the examined samples,
tissue identification of NK cells was based on strong CD16
immunostaining, which was frequently accompanied by
CD57 immunoreactivity. Tissue sections from hyper-
trophic tonsils were used as positive markers. Diami-
nobenzidine tetrahydrochloride 0.06% in phosphate-
buffered saline buffer containing 0.03% hydrogen perox-
ide was used as a chromogen. Images were acquired using
a Zeiss Axiolab microscope (Carl Zeiss GmbH, Jena, Ger-
many) with a mechanical stage, fitted in a Sony-iris CCD
video camera (Sony, Tokyo, Japan). The video camera was
connected to a Pentium II PC, loaded with the appropriate
image analysis software (Sigma Scan Pro, Science, Erkrath,
Germany). Slides were examined at a ×200 magnification.
The ratio, expressed in percentile proportion (%),
between the number of immunohistochemically positive-
stained cells and the total number (stained and
unstained) of lymphocytes was calculated. All tumors had
been characterized according to the following classical
clinical and pathological variables: patient gender (male
52, female 30, 63.4% and 36.6%, respectively) and age
(mean: 75.9, median: 76, ranging between 35–95 years),
tumor location (rectum 27, 32.9%, sigmoid 26, 31.7%,
descending colon 4, 4.8%, transverse colon 5, 6%, ascend-
ing colon 10, 12.1%, cecum 10, 12.1%), size (mean diam-
eter: 4.4 cm, median diameter: 4 cm, ranging between
1.2–10 cm), grade (I: 24 cases, 29.3%, II: 48 cases, 58.5%,
III: 10 cases, 12.2%), bowel wall invasion (present in 66
cases, 80.5%), lymph node metastases (present in 33
cases, 40.2%) and Dukes' stage (A: 5, 6.1%, B: 44, 53.7%,
C: 29, 35.4%, "D": 4, 4.9%). All "D" Dukes' stage cases
involved hepatic metastases. The tumors were categorized
according to their location into two larger groups: those
involving the rectum as well as the left colon (57 cases,
69.5%) and those involving the right colon (25 cases,
30.5%). This was performed for reasons of statistical
analysis.
Moreover, positive cases were divided into two groups:
those in which immunopositive cells ranged from 0–9%
of the total number of lymphocytes ("weak" tissue pres-
ence of NK cells) and those in which they were ≥10%
("strong" NK cell presence). This was performed some-
what arbitrarily, as we considered that the cutoff level of
10% is in accordance to what a pathologist would con-
sider to be the cutoff level between "negative" and "posi-
tive" cases in a qualitative examination, and in order to
perform statistical analysis. Associations of NK cell pres-
ence with the patients' sex, tumor location, grade, and
presence of bowel wall invasion, as well as lymph node
metastases and Dukes' stage were examined using chi-
square statistics; associations with the patients' age and
tumor size were determined using the Mann-Whintey U
test.
Results
NK cells were detectable in the primary tumor site of 79
cases (96.3%); their percentages were up to 32% of the
primary site lymphocytes (Figure). Of the 33 cases with
metastatic lymph nodes, NK cells were found in 27 cases
(81.8%); moreover, NK cells were found among liver lym-
phocytes in 3 of the total 4 cases with hepatic metastases
(75% of stage "D" cases).
Forty-nine of the 82 primary tumors (59.8%) had a
"weak" tissue presence of NK cells (0–9%), whereas the
remaining 33 primary tumors (40.2%) had a "strong" NK
cell presence (≥10%). Of the 33 cases with metastatic
lymph nodes, 18 cases (54.5%) had "weak" and 15
"strong" NK cell presence.BMC Gastroenterology 2004, 4:20 http://www.biomedcentral.com/1471-230X/4/20
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NK cell presence in the primary tumor site was not associ-
ated with the patients' sex (chi-square, p = 0.462), tumor
size (Mann-Whintey U test, p = 0.377), tumor location
(chi-square, p = 0.262), tumor differentiation (chi-square,
p = 0.556), wall invasion (chi-square, p = 0.999), the pres-
ence of metastatic lymph nodes (chi-square, p = 0.720), or
Dukes' stage (chi-square, p = 0.992). However, a negative
association between the presence of NK cells at the pri-
mary tumor site with the patients' age was noticed (Mann-
Whitney U test, p = 0.031).
Moreover, the presence of NK cells in the metastatic
lymph nodes was not associated with the patients' sex
(chi-square, p = 0.999), age (Mann-Whintey U test, p = p
= 0.212), tumor size (Mann-Whintey U test, p = 0.729),
tumor location (chi-square, p = 0.442), tumor differentia-
tion (chi-square, p = 0.872), wall invasion (chi-square, p
= 0.999), or Dukes' stage (C or D) (chi-square, p = 0.308).
Discussion
Although colorectal adenocarcinoma has been character-
ized as a model neoplasm in which clinical prognosis is
mainly determined by the histological stage, pathologic
markers often fail to predict the prognosis of a great
number of patients. This has necessitated the evaluation
of several alternative prognostic markers [1]. Immunohis-
tochemical studies have proved useful in the evaluation of
such potential markers; although they are relatively cheap
and easy-to-perform, they may be as effective as other
advanced molecular techniques in determining the role of
several molecules in human carcinogenesis [6].
CD16 and CD57 were chosen in the present study, as they
are markers of the presence of NK cells, a cellular line
which could reasonably play a significant role in the
pathophysiology of colorectal adenocarcinoma. NK cells
were considerably present in the primary tumor site, as
well as the metastatic lymph nodes of many cases in our
series. This observation is in line with data deriving from
the literature [7]. NK cell presence had no correlation with
the clinical or pathological variables of our series, besides
a negative association between their presence at the pri-
mary tumor site and the patients' age (p = 0.031), i.e. less
NK cells were found in the stroma of the primary tumor
site in the older patients of our study. Reports concerning
alterations of the number and/or the cytotoxicity of NK
cells in patients of older ages seem to be controversial [8-
14]; this has been attributed to the diversity of the param-
eters examined in these studies [8]. In most reports,
advanced age results in an increase of the number of cir-
culating NK cells [8-10]; however, other studies point out
that although total levels of NK cells actually remain
steady, some of their biologically active sub-populations
actually diminish [11,12]. The cytotoxicity of NK cells on
the other hand, has been reported to increase [13], remain
steady [8,14] or diminish [12] in patients of older age;
some reports connect presence of certain nutrients and
hormonal factors with the maintenance of NK cytotoxicity
in these patients [8,14].
However, what seems to be pivotal for rapid and efficient
migration of NK cells from the circulation to the tumor
stroma, is the expression of appropriate adhesion mole-
cules [15]. As expression of adhesion molecules in lym-
phocytes, monocytes and the interstitial tissue decreases
with age [16] this might result in decreased adhesion mol-
ecule-mediated migration of NK cells to the tumor stroma
in the older-aged patients of our series; this could possibly
explain the negative association observed in our study
[5,15].
In conclusion, our findings suggest that less NK cells are
found in the stroma surrounding the primary tumor site
in older patients with colorectal adenocarcinoma. This
could possibly be attributed to decreased adhesion mole-
cule-mediated migration; however, this hypothesis needs
to be further investigated through more studies.
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